1. Home
  2. TRVI vs HSTM Comparison

TRVI vs HSTM Comparison

Compare TRVI & HSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRVI
  • HSTM
  • Stock Information
  • Founded
  • TRVI 2011
  • HSTM 1990
  • Country
  • TRVI United States
  • HSTM United States
  • Employees
  • TRVI N/A
  • HSTM N/A
  • Industry
  • TRVI Biotechnology: Pharmaceutical Preparations
  • HSTM Computer Software: Programming Data Processing
  • Sector
  • TRVI Health Care
  • HSTM Technology
  • Exchange
  • TRVI Nasdaq
  • HSTM Nasdaq
  • Market Cap
  • TRVI 1.1B
  • HSTM 864.6M
  • IPO Year
  • TRVI 2019
  • HSTM 2000
  • Fundamental
  • Price
  • TRVI $9.64
  • HSTM $26.95
  • Analyst Decision
  • TRVI Strong Buy
  • HSTM Hold
  • Analyst Count
  • TRVI 9
  • HSTM 2
  • Target Price
  • TRVI $20.72
  • HSTM $28.00
  • AVG Volume (30 Days)
  • TRVI 2.6M
  • HSTM 191.3K
  • Earning Date
  • TRVI 11-05-2025
  • HSTM 10-20-2025
  • Dividend Yield
  • TRVI N/A
  • HSTM 0.46%
  • EPS Growth
  • TRVI N/A
  • HSTM 14.03
  • EPS
  • TRVI N/A
  • HSTM 0.67
  • Revenue
  • TRVI N/A
  • HSTM $295,211,000.00
  • Revenue This Year
  • TRVI N/A
  • HSTM $4.90
  • Revenue Next Year
  • TRVI N/A
  • HSTM $5.12
  • P/E Ratio
  • TRVI N/A
  • HSTM $40.24
  • Revenue Growth
  • TRVI N/A
  • HSTM 3.50
  • 52 Week Low
  • TRVI $2.36
  • HSTM $25.36
  • 52 Week High
  • TRVI $10.16
  • HSTM $34.24
  • Technical
  • Relative Strength Index (RSI)
  • TRVI 64.43
  • HSTM 35.07
  • Support Level
  • TRVI $8.24
  • HSTM $27.04
  • Resistance Level
  • TRVI $8.65
  • HSTM $27.94
  • Average True Range (ATR)
  • TRVI 0.51
  • HSTM 0.56
  • MACD
  • TRVI 0.10
  • HSTM -0.29
  • Stochastic Oscillator
  • TRVI 76.06
  • HSTM 1.09

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.

About HSTM HealthStream Inc.

HealthStream Inc provides workforce and provider solutions for healthcare organizations. Its reportable segments include Workforce Solutions and Provider Solutions. Workforce development solutions consist of SaaS, subscription-based products that are used by healthcare organizations. Its Provider Solutions products offer healthcare organizations software applications for administering and tracking provider credentialing, privileging, call center and enrollment activities. The company generates a majority of its revenue from Subscription Services.

Share on Social Networks: